Opto Circuits India Limited
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Opto Circuits India Limited
Teva Expects To Carve Out Sizable Niche For Uzedy In Antipsychotic Market
Uzedy was recently approved by the US FDA as an extended-release subcutaneous formula of risperidone; it is poised to be a new prong in Teva’s branded portfolio.
Teva Prepares To Launch LAI Risperidone After US Approval
Teva has indicated an imminent launch after gaining a long-awaited FDA approval for the Uzedy long-acting injectable risperidone 505(b)(2) hybrid product on which the firm has partnered with MedinCell. Pricing information has also been revealed.
Keeping Track: Gilead Gets CRL For Bulevirtide, CytoDyn Withdraws Leronlimab; Eye and CNS Drug Submissions
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker
MPP Teams Up With MedinCell For Investigational Malaria Transmission Treatment
The Medicines Patent Pool has secured a licensing deal with MedinCell for a long-acting injectable ivermectin drug formulation which could be used to prevent ongoing spread of malaria.
- Medical Devices
- Consumables, Central Supplies
- Implantable Devices
- Infusion Therapy Equipment and Supplies
- Monitoring Equipment & Devices
- Surgical Equipment & Devices
Surgical Equipment & Devices
- Minimally or Less Invasive
In Vitro Diagnostics
- Other Names / Subsidiaries
- Advanced Micronic Devices Ltd.
- Cardiac Science Corporation
- Criticare Systems Inc.
- Devon Innovations Pvt Ltd.
- Eurocor Gmbh
- Maxcor Lifescience Inc.
- Mediaid Inc.
- N.S. Remedies Pvt. Ltd.
- Opto Cardiac Care Ltd.
- Opto Circuits (Malaysia) SDN BHD
- Opto Eurocor Healthcare Ltd.
- Opto Infrastructure Ltd.
- Ormed Medical Technology Ltd.
- Unetixs Vascular Inc.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.